COVID-19 underscores need to boost pharma manufacturing in emerging markets
Windrose acquires Parioforma as part of growth strategy
Connect with regulators and industry peers
The prospects for pharma in the MINT emerging countries of Mexico, Indonesia, Nigeria and Turkey.
The factors shaping the healthcare landscape in emerging markets.